Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-01
1998-05-05
Furman, Keith C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
435 724, A61K 3839, C07K 1478
Patent
active
057474524
ABSTRACT:
The present invention provides fibronectin self-assembly sites. The invention provides a set of polypeptides derived from the first type III repeat of fibronectin which contain a fibronectin-fibronectin binding site. These polypeptides have been used to obtain a second set of polypeptides derived from the C-terminal type I repeats which contain a second fibronectin-fibronectin binding site which interacts with the first type III repeat of fibronectin. These polypeptides are capable of inhibiting fibronectin matrix assembly by interfering with fibronectin-fibronectin binding. These polypeptides are also capable of enhancing fibronectin matrix assembly and inducing disulfide cross-linking of fibronectin molecules in vitro. In addition, these polypeptides are capable of inhibiting migration of tumor cells. The polypeptides of the present invention have a number of related uses as well.
REFERENCES:
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4589881 (1986-05-01), Pierschbacher et al.
J. Cell Biology vol. 119, No. 3 Nov. 1992 pp. 663-678, Characterization of Multiple Adhesive and Counteradhesive Domains in the Extracellular Matrix Protein Cytotactin.
P.N.A.S. vol. 90, Nov. 1993 pp. 10154-10158, Multiple integrins mediate cell attachment to cytotactin/tenascin.
J. Cell. Biology vol. 99 Jul. 1984 pp. 29-36, Dualistic Nature of Adhesive Protein Function: Fibronectin and its Biologically Active Peptide Fragments Can Autoinhibit Fibronectin Function.
Keski-Oja et al., "Dimeric Character of Fibronectin, A Major Cell Surface-Associated Glycoprotein." Biochem. Biophys. Res. Commun. 74:699-706 (1977).
McDonald, J.A., "Extracellular Matrix Assembly." Annu. Rev. Cell Biol. 4:183-207 (1988).
McDonald, et al., "Fibronectin Cell-Adhesive Domain and an Amino-Terminal Matrix Assembly Domain Participate in it Assembly into Fibroblast Pericellular Matrix." J. Biol. Chem. 262:2957-2967 (1987).
McKeon-Longo et al., "Interaction of the 70,000-mol-wt Amino-terminal Fragment of Fibronectin with the Matrix-Assembly Receptor of Fibroblasts." J. Cell Biol. 100:364-374 (1985).
Mosher et al., "Assembly of Fibronectin into Extracellular Matrix." Ann. N.Y. Acad. Sci. 614:167-180 (1991).
Nagai, et al., "Monoclonal Antibody Characterization of Two Distant Sites Required for Function of the Central Cell-Binding Domain of Fibronectin in Cell Adhesion, Cell Migration, and Matrix Assembly." J. Cell Biol. 114:1295-1305 (1991).
Oh et al., "Deposition of Plasma Fibronectin in Tissues." Proc. Natl. Acad. Sci. U.S.A. 78:3218-3221 (1981).
Peters and Mosher, "Localization of Cell Surface Sites Involved in Fibronectin Fibrillogenesis." J. Cell Biol. 104:121-130 (1987).
Peters et al., "Co-assembly of Plasma and Cellular Fibronectin into Fibrils in Human Fibroblast Culture."J. Cell Biol. 111:249-256 (1990).
Pierschbacher et al., "Cell Attachment Activity of Fibronectin can be Duplicated by Small Synthetic Fragments of the Molecule." Nature 309:30-33 (1984).
Pierschbacher et al., "Synthetic Peptide with Cell Attachment Activity of Fibronectin." Proc. Natl. Acad. Sci. U.S.A. 80:1224-1227 (1983).
Pierschbacher, et al., "Variants of the Cell Recognition Site of Fibronectin That Retain Attachment Promoting Activity." Proc. Natl. Acad. Sci. U.S.A. 81:5985-5988 (1984).
Pytela, et al., "Identification and Isolation of a 140 kd Cell Surface Glycoprotein with Properties Expected of a Fibronectin Receptor." Cell 40:191-198 (1985).
Quade and McDonald, "Fibronectin's Amino-terminal Matrix Assembly Site is Located Within the 29-kDa Amino-Terminal Domain Containing Five Type I Repeats." J. Biol. Chem. 263:19602-19609 (1988).
Ruoslahti, Erkki, "Fibronectin and its Receptors." Annu. Rev. Biochem. 57:375-413 (1988).
Ruoslahti, Erkki, "Integrins." J. Clin. Invest. 87:1-5 (1991).
Schwarzbauer, J.E. "Identification of the Fibronectin Sequences Required for Assembly of a Fibrillar Matrix." J. Cell. Biol. 113:1463-1473 (1991).
Akiyama, et al., Analysis of Fibronectin Receptor Function with Monoclonal Antibodies Roles in Cell Adhesion, Migration, Matrix Assembly, and Cytoskeletal Organization. J. Cell. Biol. 109:863-875 (1991).
Ali and Hynes, "Role of Disulfide Bonds in the Attachment and Function of Large, External, Transformation-Sensitive Glycoprotein at the Cell Surface." Biochim. Biophys. Acta. 510:140-150 (1978).
Chernousov et al., "Role of the I-9 and III-1 Modules of Fibronectin in Formation of an Extracellular Fibronectin Matrix." J. Biol. Chem. 266:10851-10858 (1991).
Ehrismann et al., "Mode of Action of Fibronectin in Promoting Chicken Myoblast Attachment Mr-60,000 Gelatin-Binding Fragment Binds Native Fibronectin." J. Biol. Chem. 256:4056-4062 (1981).
Ehrismann et al., Arrangement of Attachment-Promoting, Self-Association, and Heparin-Binding Sites in Horse Serum Fibronectin. J. Biol. Chem. 257:7381-7387 (1982).
Fogerty et al., "Inhibition of Binding of Fibronectin to Matrix Assembly Sites by Anti-integrin (Alpha 5 Beta 1) Antibodies." J. Cell. Biol. 111:699-708 (1990).
Giancotti and Ruoslahti, "Elevated Levels of the Alpha 5 Beta 1 Fibronectin Receptor Suppress the Transformed Phenotype of Chinese Hamster Ovary Cells." Cell 60:849-859 (1990).
Hynes and Destree, "Extensive Disulfide Bonding at the Mammalian Cell Surface." Proc. Natl. Acad. Sci. U.S.A. 74:2855-2859 (1977).
Schwarzbauer, et al., "Efficient and Stable Expression of Recombinant Fibronectin Polypeptides." Proc. Natl. Acad. Sci. U.S.A. 84:754-758 (1987).
Woods, et al., "Fibronectin Fibril Formation Involves Cell Interactions with Tow Fibronectin Domains." Exp. Cell Res. 177:272-283 (1988).
Calaycay, J. et al., J. Biol. Chem. 260:12136-12141 (1985).
Hayashi, M. et al., J. Biol. Chem. 256:11292-112300 (1981).
Morla, et al., "A Fibronectin Self-Assembly Site Involved in Fibronectin Matrix Assembly: Reconstruction in a Synthetic Peptide." J. Cell Biol. 118(2):421-429 (1992).
Engvall and Ruoslahti, Int. J. Cancer 20:1-5 (1977).
Kornblihtt et al., EMBO J. 4:1755-1759 (1985).
Gearing et al., Bio/Technology 7:1157 (1989).
Smith et al., Gene 67:31-40 (1988).
McKeown-Longo and Mosher, J. Cell Biol. 97:466-472 (1983).
Hormann and Richter, Biopolymers 25:947-958 (1986).
Homandberg and Erickson, Biochemistry 25:6917-6925 (1986).
Homandberg, G.A., Biopolymers 26:2087-2098 (1987).
Ruoslahti and Giancotti, Integrins and Tumor Cell Dissemination, Cance, Cells 1:119-126 (1989).
Morla et al., "A Fibronectin Self-Assembly Site Involved in Fibronectin Matrix Assembly: Reconstruction in A Synthetic Peptide" J. Cell Biol. 118(2):421-429 (1992).
Morla Alex
Ruoslahti Erkki I.
Furman Keith C.
La Jolla Cancer Research Foundation
LandOfFree
Method of modulating tumor cell migration using fibronectin type does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of modulating tumor cell migration using fibronectin type, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of modulating tumor cell migration using fibronectin type will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-54540